Product NDC: | 0430-0720 |
Proprietary Name: | ESTRACE |
Non Proprietary Name: | estradiol |
Active Ingredient(s): | .5 mg/1 & nbsp; estradiol |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0430-0720 |
Labeler Name: | Warner Chilcott (US), LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040197 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111226 |
Package NDC: | 0430-0720-24 |
Package Description: | 100 TABLET in 1 BOTTLE (0430-0720-24) |
NDC Code | 0430-0720-24 |
Proprietary Name | ESTRACE |
Package Description | 100 TABLET in 1 BOTTLE (0430-0720-24) |
Product NDC | 0430-0720 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | estradiol |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20111226 |
Marketing Category Name | ANDA |
Labeler Name | Warner Chilcott (US), LLC |
Substance Name | ESTRADIOL |
Strength Number | .5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Estradiol Congeners [Chemical/Ingredient],Estrogen [EPC],Estrogen Receptor Agonists [MoA] |